Saroja Pharma Industries India Balance Sheet Annual

BSE: - | NSE: - | ISIN: - | Sector: -

39.40 0.00 (0.00%)Updated : 05 Dec 2025

Interim Data

Annual Data

Fiscal Period	2025	2024	2023	2022
Period End Date	Mar 25	Mar 24	Mar 23	Mar 22
Total Liabilities Shareholders' Equity	39.55	26.56	21.34	15.51
Cash Equivalents	0.33	0.32	0.36	0.26
Other Liabilities Total	0.00	-	-	-
Long Term Debt	1.38	2.62	2.81	1.70
Common Stock Total	4.02	4.02	2.94	0.23
Other Current Assets Total	0.16	0.59	0.77	0.13
Total Assets	39.55	26.56	21.34	15.51
Total Equity	15.68	14.64	5.09	4.03
Long Term Investments	0.34	0.20	0.14	0.04
Retained Earnings( Accumulated Deficit)	11.66	10.62	2.15	3.80
Total Common Shares Outstanding	0.40	0.40	0.40	0.40
Tangible Book Valueper Share Common Eq	38.99	36.42	12.65	10.01
Total Liabilities	23.88	11.92	16.25	11.49
Total Debt	9.46	5.74	10.19	6.14
Cashand Short Term Investments	0.33	0.32	0.36	0.26
Total Receivables Net	26.62	16.29	11.15	14.23
Notes Payable/ Short Term Debt	8.08	3.11	7.38	4.44
Deferred Income Tax	0.01	0.01	0.01	0.00
Accounts Receivable- Trade Net	26.58	16.24	11.11	13.98
Property/ Plant/ Equipment Total- Net	11.12	8.64	4.00	0.34
Total Current Liabilities	22.49	9.29	13.43	9.79
Total Inventory	0.10	0.40	3.87	0.47
Accounts Payable	13.65	5.61	5.86	5.31
Other Currentliabilities Total	0.77	0.57	0.19	0.04
Total Long Term Debt	1.38	2.62	2.81	1.70
Note Receivable- Long Term	0.88	0.13	1.04	0.04
Total Current Assets	27.22	17.60	16.15	15.09
period Length	0.00	0.00	0.00	0.00
Intangibles Net	-	0.00	0.00	0.00
Other Long Term Assets Total	-	-	0.00	-